Department of Paediatrics, University of Oxford, Peter Medawar Building for Pathogen Research, South Parks Road, United Kingdom.
HIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
J Infect Dis. 2019 Apr 16;219(9):1407-1417. doi: 10.1093/infdis/jiy668.
Susceptibility to coinfections in human immunodeficiency virus (HIV)-infected patients remains increased despite antiretroviral therapy (ART). To elucidate mechanisms involved in immune reconstitution, we studied immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in children before and after ART.
We prospectively enrolled 25 HIV-infected children to study HIV-, cytomegalovirus (CMV)-, and tuberculosis (TB)-specific T-cell responses before and 1 year after initiation of ART using intracellular cytokine (interleukin-2, interferon-γ, tumor necrosis factor-α) staining assays after in vitro stimulation. We further measured expression of activation, immune exhaustion, and memory phenotype markers and studied proliferative responses after antigen stimulation.
We observed differential, pathogen-specific changes after 1 year of ART in cytokine profiles of CD4 T-cell responses that were associated with shifts in memory phenotype and decreased programmed cell death 1 (PD-1) expression. The proliferative capacity of HIV- and PPD-specific responses increased after 1 year of ART. Of note, the recovery of CMV- and TB-specific responses was correlated with a decrease in PD-1 expression (r = 0.83, P = .008 and r = 0.81, P = .0007, respectively).
Reconstitution of immune responses on ART is associated with alterations in T-cell phenotype, function, and PD-1 expression that are distinct for HIV, TB, and CMV. The PD-1 pathway represents a potential target for immunotherapy in HIV-infected patients on ART with insufficient immune reconstitution.
尽管接受了抗逆转录病毒疗法(ART),但人类免疫缺陷病毒(HIV)感染患者仍易发生合并感染。为了阐明免疫重建相关的机制,我们研究了接受 ART 治疗前后儿童的免疫激活、免疫衰竭以及 HIV 和共病原体特异性 T 细胞反应。
我们前瞻性纳入 25 例 HIV 感染患儿,使用细胞内细胞因子(白细胞介素-2、干扰素-γ、肿瘤坏死因子-α)染色分析,在体外刺激后,研究接受 ART 治疗前和治疗 1 年后 HIV、巨细胞病毒(CMV)和结核(TB)特异性 T 细胞反应,进一步检测激活、免疫衰竭和记忆表型标志物的表达,并研究抗原刺激后的增殖反应。
我们观察到接受 ART 治疗 1 年后,CD4 T 细胞反应的细胞因子谱出现了不同的、病原体特异性的变化,这与记忆表型的转变和程序性细胞死亡 1(PD-1)表达的减少有关。HIV 和 PPD 特异性反应的增殖能力在接受 ART 治疗 1 年后增加。值得注意的是,CMV 和 TB 特异性反应的恢复与 PD-1 表达的下降相关(r = 0.83,P =.008 和 r = 0.81,P =.0007)。
ART 治疗中免疫反应的重建与 HIV、TB 和 CMV 之间具有独特差异的 T 细胞表型、功能和 PD-1 表达的改变有关。PD-1 通路是 ART 治疗中免疫重建不足的 HIV 感染患者免疫治疗的一个潜在靶点。